文献速递流行病学与生物统计

间歇性禁食策略对体重及其他心血管代谢危险因素的影响:随机临床试验的系统综述与网络Meta分析

Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors: systematic review and network meta-analysis of randomised clinical trials.
PubMed 文献 · BMJ · 2025-06-18

本系统综述与网络Meta分析检索Medline、Embase与central数据库(截至2024年11月14日),纳入99项随机临床试验共6582名成人,比较间歇性禁食、持续能量限制与自由进食对体重及心血管代谢指标的影响。结果显示,与自由进食相比,所有间歇性禁食与持续能量限制策略均降低体重;与持续能量限制相比,仅隔日禁食在体重降低方面显示获益,平均差值为-1.29 kg(95%CI -1.99至-0.59),证据确定性中等。

要点

  • 与自由进食相比,所有间歇性禁食及持续能量限制策略均降低体重。
  • 与持续能量限制相比,仅隔日禁食显示体重降低获益,平均差值-1.29 kg(95%CI -1.99至-0.59),证据确定性中等。
  • 随访≥24周的试验中,仅各饮食策略与自由进食相比显示体重降低获益,间歇性禁食策略之间未见差异。

核心结论

  • 部分间歇性禁食与持续能量限制之间差异较小,隔日禁食在较短疗程试验中显示一定体重降低获益。
  • 现有证据提示间歇性禁食在体重降低及心血管代谢危险因素方面与持续能量限制具有相似获益。
  • 作者指出需要更长疗程的试验进一步证实这些发现。

研究设计与样本

  • 系统综述与网络Meta分析,数据来源为Medline、Embase与central数据库,检索时间自建库至2024年11月14日。
  • 纳入比较隔日禁食、限时进食、整日禁食、持续能量限制与自由进食的随机临床试验。
  • 共纳入99项随机临床试验,涉及6582名成人,其中720名健康、5862名存在健康问题。
  • 采用频率学派框架的网络Meta分析,效应量以平均差值及95%CI表示,证据确定性采用GRADE评估。

主要发现

  • 与自由进食相比,所有间歇性禁食和持续能量限制饮食策略均降低体重。
  • 与持续能量限制相比,隔日禁食是唯一显示体重降低获益的间歇性禁食策略,平均差值-1.29 kg(95%CI -1.99至-0.59),证据确定性中等。
  • 与限时进食相比,隔日禁食体重降低平均差值-1.69 kg(95%CI -2.49至-0.88);与整日禁食相比,隔日禁食体重降低平均差值-1.05 kg(95%CI -1.90至-0.19),两者证据确定性均为中等。
  • 随访不足24周的试验(n=76)中估计值相似;随访≥24周的试验(n=17)中,仅各饮食策略与自由进食相比显示体重降低获益。
  • 在间歇性禁食策略之间,与限时进食相比,隔日禁食降低总胆固醇、甘油三酯与非高密度脂蛋白;与整日禁食相比,限时进食使总胆固醇、低密度脂蛋白胆固醇与非高密度脂蛋白胆固醇轻度升高。

关键数值与推荐

  • 与持续能量限制相比,隔日禁食体重降低平均差值-1.29 kg(95%CI -1.99至-0.59),证据确定性中等。
  • 与限时进食相比,隔日禁食体重降低平均差值-1.69 kg(95%CI -2.49至-0.88),证据确定性中等。
  • 与整日禁食相比,隔日禁食体重降低平均差值-1.05 kg(95%CI -1.90至-0.19),证据确定性中等。
  • 间歇性禁食、持续能量限制与自由进食之间在HbA1c与高密度脂蛋白方面未见差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 随访≥24周的试验(n=17)中,间歇性禁食策略之间未见体重降低差异。
  • 作者指出需要更长疗程的试验进一步证实这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the effect of intermittent fasting diets, with continuous energy restriction or unrestricted (ad-libitum) diets on intermediate cardiometabolic outcomes from randomised clinical trials. DESIGN: Systematic review and network meta-analysis. DATA SOURCES: Medline, Embase, and central databases from inception to 14 November 2024. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Randomised clinical trials comparing the association of intermittent fasting diets (alternate day fasting, time restricted eating, and whole day fasting), continuous energy restriction, and ad-libitum diets were included. MAIN OUTCOMES: Outcomes included body weight (primary) and measures of anthropometry, glucose metabolism, lipid profiles, blood pressure, C-reactive protein, and markers of liver disease. DATA SYNTHESIS: A network meta-analysis based on a frequentist framework was performed with data expressed as mean difference with 95% confidence intervals (CIs). The certainty of the evidence was assessed using grading of recommendations assessment, development, and evaluation (GRADE). RESULTS: 99 randomised clinical trials involving 6582 adults of varying health conditions (720 healthy, 5862 existing health conditions) were identified. All intermittent fasting and continuous energy restriction diet strategies reduced body weight when compared with ad-libitum diet. Compared with continuous energy restriction, alternate day fasting was the only form of intermittent fasting diet strategy to show benefit in body weight reduction (mean difference -1.29 kg (95% CI -1.99 to -0.59), moderate certainty of evidence). Additionally, alternate day fasting showed a trivial reduction in body weight compared with both time restricted eating and whole day fasting (mean difference -1.69 kg (-2.49 to -0.88) and -1.05 kg (-1.90 to -0.19), respectively, both with moderate certainty of evidence). Estimates were similar among trials with less than 24 weeks follow-up (n=76); however, moderate-to-long-term trials (≥24 weeks, n=17) only showed benefits in weight reduction in diet strategies compared with ad-libitum. Furthermore, in comparisons between intermittent fasting strategies, alternate day fasting lowered total cholesterol, triglycerides, and non-high density lipoprotein compared with time restricted eating. Compared with whole day fasting, however, time restricted eating resulted in a small increase in total cholesterol, low density lipoprotein cholesterol, and non-high density lipoprotein cholesterol. No differences were noted between intermittent fasting, continuous energy restriction, and ad-libitum diets for HbA1c and high density lipoprotein. CONCLUSIONS: Minor differences were noted between some intermittent fasting diets and continuous energy restriction, with some benefit of weight loss with alternate day fasting in shorter duration trials. The current evidence provides some indication that intermittent fasting diets have similar benefits to continuous energy restriction for weight loss and cardiometabolic risk factors. Longer duration trials are needed to further substantiate these findings. TRIAL REGISTRATION: ClinicalTrials.gov NCT05309057.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Semnani-Azad Z, Khan TA, Chiavaroli L, et al. Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors: systematic review and network meta-analysis of randomised clinical trials. BMJ. 2025. PMID: 40533200. doi:10.1136/bmj-2024-082007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。